Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sidapharm is a private Greek ophthalmic medical device manufacturer focused on CE-certified ophthalmic and medical disposables for eye surgery and related procedures. The company was founded in 2000 and is based in Thessaloniki, Greece. Its commercial portfolio includes intraocular lenses, preloaded IOL systems, ophthalmic viscosurgical devices, balanced salt solution, trypan blue, cannulas, microsurgical knives, gases, silicone oils, PFCL products, surgical packs, apparel, and ophthalmic instruments. Sidapharm appears to operate as a commercial-stage manufacturer and distributor serving ophthalmology customers and distribution partners across multiple international markets. The business is healthcare-related, but it is not a therapeutics biotech or drug-development company; it is primarily an ophthalmic medical products company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sidapharm.